# A Study of VCT220 in Participants With Hypertension and Obesity or Overweight

Study · id `cardio:ct-nct07360275` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07360275](<https://clinicaltrials.gov/study/NCT07360275>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07360275

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT07360275. Randomized; double masking; primary purpose treatment. Start 2026-03-01 (actual); primary completion 2026-10-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT07360275, source copy `cardio:ctgov-nct07360275-2026-09-21`, retrieved 2026-10-26)
- Started: 2026-03-01 (actual) (ClinicalTrials.gov record NCT07360275, source copy `cardio:ctgov-nct07360275-2026-09-21`, retrieved 2026-10-26)
- Primary completion: 2026-10-30 (anticipated) (ClinicalTrials.gov record NCT07360275, source copy `cardio:ctgov-nct07360275-2026-09-21`, retrieved 2026-10-26)
- Completion: 2026-12-20 (anticipated) (ClinicalTrials.gov record NCT07360275, source copy `cardio:ctgov-nct07360275-2026-09-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07360275, source copy `cardio:ctgov-nct07360275-2026-09-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07360275-2026-09-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
- Acronym: VICTOR-HTN
- Condition: Hypertension
- Intervention (Drug): VCT220 Tablet
- Intervention (Drug): VCT220 Placebo Tablet
- Lead sponsor: Vincentage Pharma Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: f3257b598343bf404b1b6888c50ae13d0aae5116cb68a279a0cd61c24cd9806c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
